ETRADE Capital Management LLC Raises Stake in Colgate-Palmolive Company (CL)

ETRADE Capital Management LLC raised its position in shares of Colgate-Palmolive Company (NYSE:CL) by 0.1% during the third quarter, according to its most recent disclosure with the SEC. The firm owned 24,233 shares of the company’s stock after buying an additional 15 shares during the period. ETRADE Capital Management LLC’s holdings in Colgate-Palmolive Company were worth $1,797,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. ClariVest Asset Management LLC acquired a new position in Colgate-Palmolive Company during the second quarter worth $198,000. Atlas Brown Inc. increased its stake in Colgate-Palmolive Company by 0.5% in the second quarter. Atlas Brown Inc. now owns 17,955 shares of the company’s stock worth $1,314,000 after buying an additional 90 shares during the last quarter. Cypress Capital Management LLC WY acquired a new stake in Colgate-Palmolive Company during the second quarter worth approximately $348,000. Chicago Equity Partners LLC bought a new position in shares of Colgate-Palmolive Company during the second quarter valued at $444,000. Finally, Meag Munich Ergo Kapitalanlagegesellschaft MBH boosted its position in shares of Colgate-Palmolive Company by 6,022.3% in the second quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 342,850 shares of the company’s stock valued at $24,963,000 after buying an additional 337,250 shares in the last quarter. Institutional investors and hedge funds own 73.24% of the company’s stock.

Institutional Ownership by Quarter for Colgate-Palmolive Company (NYSE:CL)

Shares of Colgate-Palmolive Company (NYSE:CL) opened at 67.74 on Wednesday. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $75.38. The stock has a market capitalization of $60.13 billion, a price-to-earnings ratio of 24.90 and a beta of 0.70. The firm’s 50-day moving average is $66.44 and its 200-day moving average is $69.83.

Colgate-Palmolive Company (NYSE:CL) last released its quarterly earnings results on Friday, January 27th. The company reported $0.75 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.75. Colgate-Palmolive Company had a return on equity of 4,897.09% and a net margin of 16.06%. The company earned $3.72 billion during the quarter, compared to analysts’ expectations of $3.87 billion. During the same period in the previous year, the firm posted $0.73 earnings per share. The business’s revenue for the quarter was down 4.6% compared to the same quarter last year. On average, equities research analysts anticipate that Colgate-Palmolive Company will post $2.91 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 15th. Investors of record on Monday, January 23rd will be paid a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a dividend yield of 2.30%. The ex-dividend date of this dividend is Thursday, January 19th. Colgate-Palmolive Company’s payout ratio is currently 57.35%.

This piece of content was first reported by Mideast Time and is the property of of Mideast Time. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.mideasttime.com/etrade-capital-management-llc-raises-stake-in-colgate-palmolive-company-cl/1536906.html.

A number of equities analysts have weighed in on the company. RBC Capital Markets set a $71.00 price objective on Colgate-Palmolive Company and gave the stock a “hold” rating in a research note on Monday, January 2nd. Barclays PLC reaffirmed a “hold” rating and issued a $63.00 target price on shares of Colgate-Palmolive Company in a research note on Tuesday, January 10th. B. Riley reiterated a “neutral” rating and set a $78.00 price target on shares of Colgate-Palmolive Company in a report on Wednesday, November 2nd. Zacks Investment Research cut shares of Colgate-Palmolive Company from a “hold” rating to a “sell” rating in a research report on Tuesday, December 27th. Finally, Wells Fargo & Company reissued a “market perform” rating on shares of Colgate-Palmolive Company in a research report on Tuesday, November 15th. One analyst has rated the stock with a sell rating, fourteen have issued a hold rating and two have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $73.42.

In other news, Director Stephen I. Sadove sold 8,000 shares of Colgate-Palmolive Company stock in a transaction dated Friday, February 3rd. The shares were sold at an average price of $66.00, for a total transaction of $528,000.00. Following the completion of the sale, the director now directly owns 33,761 shares in the company, valued at $2,228,226. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Patricia Verduin sold 3,833 shares of Colgate-Palmolive Company stock in a transaction dated Tuesday, January 17th. The stock was sold at an average price of $65.99, for a total transaction of $252,939.67. Following the sale, the insider now owns 54,924 shares of the company’s stock, valued at $3,624,434.76. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 23,607 shares of company stock worth $1,562,774. Corporate insiders own 1.05% of the company’s stock.

About Colgate-Palmolive Company

Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

5 Day Chart for NYSE:CL

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.